Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
259,967,612
-
Number of holders
-
786
-
Total 13F shares, excl. options
-
198,916,477
-
Shares change
-
+3,623,693
-
Total reported value, excl. options
-
$5,565,036,784
-
Value change
-
+$117,628,593
-
Put/Call ratio
-
54%
-
Number of buys
-
308
-
Number of sells
-
-379
-
Price
-
$27.93
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q4 2022
863 filings reported holding OGN - Organon & Co. - Common Stock as of Q4 2022.
Organon & Co. - Common Stock (OGN) has 786 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198,916,477 shares
of 259,967,612 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31,471,695 shares), BlackRock Inc. (16,387,716 shares), Mawer Investment Management Ltd. (13,179,805 shares), STATE STREET CORP (12,861,138 shares), JANUS HENDERSON GROUP PLC (12,020,574 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (7,537,904 shares), LORD, ABBETT & CO. LLC (7,460,760 shares), GEODE CAPITAL MANAGEMENT, LLC (5,851,659 shares), Bank of New York Mellon Corp (5,494,292 shares), and Invesco Ltd. (4,467,573 shares).
This table shows the top 786 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.